Partners

 

Gold Partners

 
Cantor Colburn, one of the largest full-service IP law firms in the U.S., is the fastest also the growing patent firm over the last ten years. Cantor Colburn is ranked #4 for design patents, #6 for utility patents and #10 for trademarks. The firm’s Litigation Department has also received national recognition. More than 100 attorneys and agents provide counsel to clients worldwide from offices in Hartford, Washington, D.C., Atlanta, Houston, and Detroit. Cantor Colburn is proud to be named one of the Top 100 Firms for Minority Attorneys (IP Law360).
Our Pharmaceutical IP Services Practice Group handles litigation, patent prosecution, inter partes reviews and other Patent Office review proceedings, opinions, landscapes, competitive intelligence, transactional services, portfolio management, biosimilar and interchangeable biological drugs, and more. The Pharmaceutical IP Services Practice Group operates as a team, in which each practice area – patent and litigation – excels at its distinct area, while providing a seamless, one-stop service experience for clients seeking comprehensive pharmaceutical IP services.
With highly specialized knowledge and in-depth understanding of clients' businesses, the firm supports the technological innovations that are driving the world economy
www.cantorcolburn.com
Ranked among the top 100 law firms in the country, Cozen O’Connor has more than 700 attorneys in 26 cities across two continents. We are a full-service firm with nationally recognized practices in litigation, business law, and government relations, and our attorneys have experience operating in all sectors of the economy. Cozen O’Connor’s dedicated Hatch-Waxman & Biologics team are seasoned trial lawyers who also have advanced scientific degrees and industry experience in fields including organic chemistry, molecular cell biology and biophysics. Our team has handled more than 70 Hatch-Waxman matters in the last five years. Moreover, our team is the first to try a case under the BPCIA, obtaining a verdict of non-infringement for the biosimilar applicant. We then obtained a unanimous decision from the Federal Circuit affirming the district court’s non-infringement judgment.
www.cozen.com
Green Griffith focuses exclusively on IP issues involving pharmaceuticals, chemistry and biotechnology—specializing in litigation. Our attorneys share decades of litigation experience assisting both generics and brand companies navigate the Hatch-Waxman Act. As stated in AIM Patent 1000 (2017): “Green, Griffith is a uniquely talented and experienced intellectual property firm that has been making serious waves in the biopharmaceutical market. As for the Green, Griffith modus operandi, they are tirelessly committed to helping their clients succeed; collaborating with their clients as strategic partners – albeit partners who happen to be excellent at litigation.”
Acknowledged leaders in our field, we partner with our clients to provide strategic formulation development and litigation counseling concerning IP and FDA exclusivity issues affecting 505(b)(1), 505(b)(2) and ANDA applications. Pre-litigation, we provide strategies and opinions on API and excipient selection, trade dress, formulation attributes and labeling. Our trial attorneys—who have hard science backgrounds in chemistry, biology and/or biotechnology—then work with each client to execute the desired strategy—whether this involves litigation in the federal courts or IPR practice before the PTAB.
www.greengriffith.com
Maynard Cooper & Gale (Maynard) resolves complex business challenges with integrated legal solutions drawn from more than 290 attorneys across its national footprint. We collaborate with our clients to understand their businesses so that we are meticulously positioned to generate legal outcomes that advance stated business goals. Our one-firm, client-centric approach leverages the vast experience of our attorneys and a national geographic footprint to deliver comprehensive counsel for Fortune 500, publicly traded, and emerging and established companies operating across key industry sectors. Maynard serves clients nationwide from its offices in Alabama, California, New York, Tennessee, Texas, and Washington, D.C.
 

Silver Partners

 
Xact Data Discovery (XDD) is a leading international provider of eDiscovery, data management and managed review services for law firms and corporations. XDD helps clients optimize their eDiscovery matters by orchestrating precision communication between people, processes, technology and data. XDD has 16 offices throughout the United States and two locations in India. XDD offers exceptional customer service with a commitment to responsive, transparent and timely communication to ensure clients remain informed throughout the entire discovery life cycle.
www.xactdatadiscovery.com
Arent Fox LLP is internationally recognized in core industries where business and the law intersect. With more than 450 lawyers, the firm provides strategic legal counsel and multidisciplinary solutions to a global roster of corporations, governments, and trade associations.

As one of the leading full-service Intellectual Property firms in the country, our team has the resources to serve our clients in the pharmaceutical industry. Our work includes providing patent and FDA regulatory counseling prior to ANDA or 505(b)(2) filing, opinions, counseling in the area of biosimilars, and Hatch-Waxman and 505(b)(2) litigation. The Arent Fox team has successfully represented multiple generic pharmaceutical companies in cases involving dozens of drugs.
www.arentfox.com
We are a leading firm of Intellectual Property professionals, including UK Chartered and European Patent Attorneys, UK Chartered and European Trade Mark Attorneys and IP Solicitors, based in London. We have been providing specialist advice and IP services to our clients since 1911. Our Chemistry, Biotechnology and Pharmaceuticals team enjoys an international reputation, and benefits from attorneys and solicitors with a wide range of professional and academic backgrounds. We are proud to represent a large number of companies within the pharmaceutical and biotechnology industry, including Indian companies, on contentious and non-contentious matters touching on every stage of the product life-cycle.

“A.A. Thornton & Co.’s level of service is ‘outstanding’ – ‘timeliness and appropriateness of advice are a constant’ according to clients, who rate the level of scientific knowledge displayed by the partners and associate lawyers as ‘excellent’ (Legal 500 2017).
www.aathornton.com
Goldberg Segalla is one of the largest and fastest-growing law firms headquartered in the United States, with a footprint that reaches from Los Angeles to London. Its more than 400 attorneys serve regional, national, and international clients from over 20 offices, with teams based in New York, Chicago, Philadelphia, Miami, and other major business and economic centers across 10 states. An AmLaw200 firm, Goldberg Segalla handles all forms of dispute resolution, patent litigation, and complex transactions, and provides proactive legal and regulatory counsel to help companies and professionals from a wide range of industries minimize and manage risk.
www.goldbergsegalla.com
 

Associate Partner

LexOrbis is a full-service Indian IP firm with offices in New Delhi, Mumbai and Bangalore with over 190 personnel including 80 attorneys. The Firm is ranked amongst the Top-5 IP firms and as “fastest growing” IP firm in India. The Patent practice group has over 55 patent attorneys with expertise in chemical, pharmaceutical, life sciences and a broad range of engineering subjects. The trademark/design group has over 16 attorneys and they are managing global portfolios of a large number of global and domestic businesses. IP Enforcement and Litigation group have 10 seasoned litigators with vast experience. The Firm’s services include Indian and global IP (patents/designs/trademark/copyright/GI/plant varieties) portfolio development and management, advisory and documentation services on IP transactions/technology-content transfers and IP enforcement and dispute resolutions at all forums across India. They represent some of the leading Fortune 500 technology companies, leading brand owners, content developers and global publication houses.
 

Cocktail Partners

 
The Locke Lord team pulls together lawyers from across the firm’s many practice areas and offices who are best suited to meet the legal challenges of pharmaceutical and biotechnology industry clients from IP-related issues to business disputes and antitrust concerns. Our formidable team combines strong scientific understanding, courtroom experience, regulatory experience and decades of industry knowledge. A variety of pharmaceutical and biotechnology companies across the world rely on Locke Lord. Our lawyers have technical skills, specific experience, and advanced degrees in a variety of scientific fields, including: pharmaceuticals; organic, inorganic and industrial chemistry; biochemistry; biotechnology; and genetics. Our real world experience enables us to counsel clients on virtually any legal issue surrounding a lawsuit or transaction without losing sight of the science or technology involved.
www.lockelord.com
HGF is a leading European intellectual property law firm engaged by companies and research organisations having patents, brands and designs at the core of their business. We provide commercially-relevant, cost-effective advice for IP matters.
HGF advises on the creation of strategic IP assets around the world. HGF provides world-class expertise in the origination, enforcement and defence of IP rights. Our approach is proactive and we work with our clients to find cost-effective, practical solutions to commercial issues. HGF provides:
  • advice relevant to specific client business needs;
  • strategic, proactive approach in assisting the growth of our clients’ businesses;
  • strong collaborative working relationships with clients.

www.hgf.com
 

Lanyard Partner

RMMS consists of over 30 attorneys focused exclusively on life sciences patent and regulatory counseling, patent litigation under Hatch-Waxman and the BPCIA, as well as post-grant review before the PTAB. RMMS attorneys embrace the science of a case, and have made it an integral part of our strategy in the over 300 pharmaceutical litigation matters clients have entrusted to us.

We understand that patent litigation is rarely an end-game, and that business decisions made throughout the product development, regulatory review, litigation, and commercialization process are equally critical to the company’s strategic plans involving any one product or a product portfolio.

 


Event Partners

Gold Partners


Silver Partners


Associate Partner


Cocktail Partners

Lanyard Partner


Media Partners



Website by: Xpoteck